Amplify Treatments Testing & Advancements ETF

GERM tracks a tier-weighted, narrow index of US-listed, global biotech companies that are engaged in the testing and treatments of infectious diseases.

GERM tracks a tier-weighted index of US-listed healthcare companies engaged in treatments, testing, and other medical advancements. Holdings are selected by the index committee.

Amplify Emerging Markets FinTech ETF

Amplify Inflation Fighter ETF

CHICAGO, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Amplify ETFs, a leading provider of exchange traded funds, today announced the scheduled liquidation of three ETFs (the “Funds”). The Funds scheduled for liquidation include: ETF Name Ticker Amplify Emerging Markets FinTech ETF EMFQ Amplify Treatments, Testing and Advancements ETF GERM Amplify Inflation Fighter ETF IWIN Based on the recommendation of Amplify Investments LLC, the Funds' investment adviser, the Board of Trustees of the Amplify ETF Trust unanimously determined that it is in the best interests of the Funds and their shareholders to liquidate the Funds.

Amplify ETFs to Liquidate Three ETFs

Amplify AI Powered Equity ETF

Amplify Travel Tech ETF

Amplify Cash Flow Dividend Leaders ETF

Amplify CWP Dividend & Option Income ETF

Amplify Etho Climate Leadership US ETF

Amplify Cybersecurity ETF

Amplify Cash Flow High Income Etf

Amplify International Enhanced Dividend Income ETF

Amplify BlackSwan ISWN ETF

Amplify Alternative Harvest ETF

Amplify US Alternative Harvest ETF

Amplify Natural Resources Dividend Income ETF

Amplify BlackSwan Tech & Treasury ETF

Amplify Samsung Sofr Etf

Amplify Blackswan Growth & Treasury Core ETF

YieldShares High Income ETF

CHICAGO, June 27, 2024 (GLOBE NEWSWIRE) -- Amplify ETFs announces June income distributions for its ETFs. ETF Name Ticker   Amount per Share Ex-Date Record Date Payable Date Amplify AI Powered Equity ETF AIEQ   $0.05503 6/27/2024 6/27/2024 6/28/2024 Amplify Travel Tech ETF AWAY   $0.03617 6/27/2024 6/27/2024 6/28/2024 Amplify Cash Flow Dividend Leaders ETF COWS   $0.05711 6/27/2024 6/27/2024 6/28/2024 Amplify CWP Enhanced Dividend Income ETF DIVO   $0.15556 6/27/2024 6/27/2024 6/28/2024 Amplify Etho Climate Leadership U.S. ETF ETHO   $0.13457 6/27/2024 6/27/2024 6/28/2024 Amplify Treatments, Testing and Advancements ETF GERM   $0.08798 6/27/2024 6/27/2024 6/28/2024 Amplify Cybersecurity ETF HACK   $0.02578 6/27/2024 6/27/2024 6/28/2024 Amplify Cash Flow High Income ETF HCOW   $0.17040 6/27/2024 6/27/2024 6/28/2024 Amplify International Enhanced Dividend Income ETF IDVO   $0.15320 6/27/2024 6/27/2024 6/28/2024 Amplify BlackSwan ISWN ETF (International) ISWN   $0.14293 6/27/2024 6/27/2024 6/28/2024 Amplify Alternative Harvest ETF MJ   $0.16966 6/27/2024 6/27/2024 6/28/2024 Amplify U.S. Alternative Harvest ETF MJUS   $0.01565 6/27/2024 6/27/2024 6/28/2024 Amplify Natural Resources Dividend Income ETF NDIV   $0.13227 6/27/2024 6/27/2024 6/28/2024 Amplify BlackSwan Tech & Treasury ETF QSWN   $0.14215 6/27/2024 6/27/2024 6/28/2024 Amplify Samsung SOFR ETF SOF   $0.44497 6/27/2024 6/27/2024 6/28/2024 Amplify BlackSwan Growth & Treasury Core ETF SWAN   $0.19349 6/27/2024 6/27/2024 6/28/2024 Amplify High Income ETF YYY   $0.12000 6/27/2024 6/27/2024 6/28/2024 About Amplify ETFs Amplify ETFs, sponsored by Amplify Investments, has over $9 billion in assets across its suite of ETFs (as of 5/31/2024).

Amplify ETFs Declares June Income Distributions for its ETFs

Principal Healthcare Innovators Index ETF

Fidelity MSCI Health Care ETF

First Trust Health Care AlphaDEX Fund

Global X Health Care Covered Call & Growth ETF

SPDR S&P Insurance ETF

Direxion Daily Pharmaceutical & Medical Bull 3X Shares

Invesco DWA Healthcare Momentum ETF

Invesco S&P 500 Equal Weight Health Care ETF

SPDR Portfolio S&P 500 Growth ETF

SPDR Portfolio S&P 500 Value ETF

Amplify Weight Loss Drug & Treatment ETF

Vanguard Health Care ETF

SPDR S&P Biotech ETF

SPDR S&P Health Care Equipment ETF

SPDR S&P Health Care Services ETF

Health Care Select Sector SPDR Fund

SPDR S&P Pharmaceuticals ETF

Sometimes it feels like it's Nvidia's world and we all just live in it. Why bother with anything else?

Finding Opportunity in Unloved Healthcare ETFs

Amplify Video Game Tech ETF

Amplify Mobile Payments ETF

Amplify BlueStar Israel Technology ETF

Amplify Global Cloud Technology ETF

Amplify Junior Silver Miners ETF

CHICAGO, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Amplify ETFs announced today it has completed its previously announced acquisition of ETF Managers Group (ETFMG) exchange-traded fund (ETF) assets, which consist of over $3.7 billion of assets under management (AUM) across 14 ETFs (as of 1/26/2024). Amplify ETFs will now manage $9.1 billion of AUM as of 1/26/2024.

Amplify ETFs Completes Acquisition to Reach $9.1 Billion AUM Across 31 ETFs

Breakwave Dry Bulk Shipping ETF

Amplify Transformational Data Sharing ETF

Breakwave Tanker Shipping ETF

Amplify Seymour Cannabis ETF

Amplify Online Retail ETF

In June, the ETF industry learned that issuer ETF Managers Group would be selling its funds to Amplify ETFs. The transaction, once completed, will bring Amplify's total AUM to $8 billion invested across 29 ETFs.

Amplify's Christian Magoon on Purchase of ETFMG's ETFs

Asian Growth CUBS ETF

TrueShares ESG Active Opportunities ETF

Hartford Schroders ESG US Equity ETF

Global X MSCI Nigeria ETF

Nightshares Russell 2000 ETF

Nightshares Russell 1000 ETF

Revere Sector Opportunity ETF

The week ending Friday, July 21, has been busy for the ETF industry, though launches were muted. A total of seven funds rolled out, which suggests the market could be entering some kind of summer slump.

This Week in ETFs: A Summer Slowdown

VanEck Vectors Biotech ETF

First Trust Morningstar Dividend Leaders Index Fund

First Trust Nasdaq Pharmaceuticals ETF 

iShares Core High Dividend ETF

Invesco Nasdaq Biotechnology ETF

Horizon Kinetics Medical ETF

Moderna

Novavax

Pfizer

Invesco Dynamic Pharmaceuticals ETF

The FDA advised to Pfizer, Moderna and Novavax to manufacture single-strain jabs targeting the omicron subvariant XBB.1.5 should prove to be a victory for some biotech ETFs.

Biotech ETFs in Focus on Covid Vaccines' Fall Rollout

Global X Longevity Thematic ETF 

ARK Genomic Revolution Multi-Sector ETF

Virtus LifeSci Biotech Clinical Trials ETF

Virtus LifeSci Biotech Products ETF

BlackRock Future Health ETF

Loncar Cancer Immunotherapy ETF

Global X Telemedicine & Digital Health ETF

First Trust NYSE Arca Biotechnology Index Fund

Global X Genomics & Biotechnology ETF

 Franklin Genomic Advancements ETF

ROBO Global Healthcare Technology and Innovation ETF

iShares Nasdaq Biotechnology ETF

iShares Genomics Immunology and Healthcare ETF

iShares U.S. Pharmaceuticals ETF

iShares U.S. Healthcare Providers ETF

iShares U.S. Medical Devices ETF

iShares Global Healthcare ETF

iShares U.S. Healthcare ETF

Eli Lilly

Global X Longevity Thematic ETF

First Trust Indxx Medical Devices ETF

Merck

Novo Nordisk

Invesco Dynamic Biotechnology & Genome ETF

Simplify Health Care ETF

VanEck Vectors Pharmaceutical ETF

Invesco S&P SmallCap Health Care ETF

ALPS Medical Breakthroughs ETF

Wisdomtree BioRevolution Fund

How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.

Can Health Care Stocks Outperform Again In 2023?

Global X Education ETF

Pacer BioThreat ETF

Direxion Work From Home ETF

COVID-themed stocks and ETFs were winners in 2020 and some parts of 2021 due to a spike in global coronavirus cases. We may see the same trend again as new COVID variants are 'pretty troublesome.

Here's Why COVID-Themed ETFs May Come Back Under the Radar

Biotechnology sector-related exchange traded funds retreated with Novavax Inc. (NasdaqGS: NVAX), plunging after the vaccine developer cut its 2022 revenue guidance in half. On Tuesday, the iShares Genomics Immunology and Healthcare ETF (IDNA) fell 4.1%, ETFMG Treatments Testing and Advancements ETF (GERM) dropped 4.3%, SPDR S&P Biotech ETF (XBI) decreased 3.

Biotech ETFs Slip After Novavax Cuts 2022 Guidance

Moderna Inc (NasdaqGS: MRNA) shares surged Wednesday, lifting biotechnology sector-related exchange traded funds, after the pharmaceutical company revealed better-than-expected profit and revenue in its latest quarterly report, along with a share buyback plan. On Wednesday, the Invesco Nasdaq Biotechnology ETF (IBBQ) increased 4.2%, the ETFMG Treatments Testing and Advancements ETF (GERM) advanced 5.

Moderna Q2 Earnings, Buyback Plans Lift Biotech ETFs

iShares Evolved U.S. Innovative Healthcare ETF

Pharma and biotech ETFs are in great shape and are trading at a one-month high level.

Pharma & Biotech ETFs at One-Month High: Here's Why

Global X MSCI China Health Care ETF

Global X China Consumer ETF

iShares MSCI China ETF

Direxion mRNA ETF

SPDR FactSet Innovative Technology ETF

The first tranche of Chinese ADRs affected by a 2020 law has been released.

China ETFs Drop On Audit Enforcement

Johnson & Johnson

Biotech ETFs was the biggest gainer last week.

Biotech ETFs That Outperformed Last Week

Wall Street was downbeat last week with all indexes in the red. Still, Healthcare sector emerged as a key winner last week.

Healthcare Emerges as Best Sector of Last Week: 5 Top ETFs

VanEck Video Gaming and eSports ETF

iShares U.S. Home Construction ETF

iShares PHLX Semiconductor ETF

Simplify Volt RoboCar Disruption and Tech ETF

Though the broad markets ended the month in red, a few sector ETFs performed remarkably well.

5 Best Sector ETFs of November

The remainder of 2021 is expected to continue reeling under the spurt in coronavirus cases. Thus, a COVID-themed ETF could be a wise choice.

Bet On COVID-Themed ETFs as New Cases Rise Globally

ETF Managers Trust - ETFMG Treatments Testing and Advancements ETF is a biotech focused ETF invested in treatments and therapies firms.

GERM ETF: A New Player In The Infectious Disease Segment

First Trust Natural Gas ETF

Invesco Dynamic Energy Exploration & Production ETF

VanEck Rare Earth/Strategic Metals ETF

Sprott Uranium Miners ETF

SPDR S&P Retail ETF

Invesco S&P SmallCap Value with Momentum ETF

We highlight seven ETFs from different segments that have outperformed and gained more than 40% in the first nine months of 2021.

7 Best ETFs of the First Nine Months of 2021

Play COVID-Themed ETFs as US Labor Day Sees Rise in New Cases

The Biden administration recently offered a $65 billion plan that U.S. officials say is aimed at combating the biological threats after the COVID-19 pandemic goes away.

Healthcare ETFs to Gain on $65-Billion Pandemic Protection Plan

Global X MSCI Argentina ETF

Roundhill Sports Betting & iGaming ETF

Global X Blockchain ETF

SPDR S&P Semiconductor ETF

Optimism about corporate earnings, U.S. FDA's full approval of Pfizer-BioNTech Covid-19 vaccine, some upbeat economic data points and the passage of the infrastructure bill helped key U.S. equity indexes go higher in August.

6 Best ETF Areas of August

Global X Cybersecurity ETF

First Trust Nasdaq Retail ETF

iShares U.S. Broker-Dealers & Securities Exchanges ETF

Invesco S&P 500 Equal Weight Materials ETF

Below are five ETFs that have gained from strong earnings results.

5 Must-Watch ETF Charts of Q2 Earnings

ETFs that look at a subsector of biotech have significantly outperformed broader biotech funds this year.

COVID Biotech ETFs Rise At Fever Pace

Wall Street analysts are bullish on stocks in almost two decades with about 56% of all recommendations on S&P 500 firms listed as buys, the highest since 2002.

ETFs to Buy on Most-Bullish Wall Street Outlook in Two Decades

News for Amplify Treatments Testing & Advancements ETF ETF (GERM)